Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Czechia / NCT07022210
Recruiting Observational

Incidence of Hypotension in the Post-anesthesia Care Unit (PACU).

NCT07022210 · tracked via the Priya Life Science Czechia tracker
Phase
Observational
Started
2025-06-15
Last updated
2025-07-10

Condition(s) studied

Hypotension During SurgerySurgery-Complications

Study summary

The perioperative period poses a heightened risk of complications for patients, including hypotension. While the issue of intraoperative hypotension is well-documented in medical literature, the occurrence and causes of hypotension in the post-anesthesia care unit often receive less attention. This phase of postoperative care, however, is vital for ensuring patient stability and preventing severe consequences. Failure to identify and manage a drop in blood pressure can lead to hypoperfusion of critical organs, increasing the risk of morbidity and mortality. The aim of this study is to examine the frequency of hypotension in the post-anesthesia care unit-defined as systolic blood pressure \<90 mmHg or a drop of more than 20% from baseline-and to identify factors contributing to its development.

Eligibility

Sex
ALL
Min age
18 Years
Max age
105 Years
Healthy volunteers
Accepted
Inclusion Criteria: * patients over 18 years old * patients undergoing a procedure under general anesthesia * patients who have consented to data processing * postoperative stay in PACU Exclusion Criteria: * patients younger than 18 years old. * patients transferred directly to the ICU/Anesthesiology and Resuscitation Department after surgery without staying in the recovery room. * patients with incomplete medical documentation or missing blood pressure values in the recovery room. * patients with a pre-existing diagnosis of resistant hypotension or unstable hemodynamics before surgery * patients with a history of long-term use of anxiolytics, antipsychotics, or other psychotropic medications that may affect cognitive function, emotional state, or predictive outcomes * patient refusal to participate in the study (including cases where they initially consented), with an emphasis on respecting patient autonomy

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Tomas Bata regional Hospital Zlín Czechia Recruiting

More Tomas Bata Hospital, Czech Republic trials in Czechia

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07022210 on ClinicalTrials.gov ↗ ← All trials in Czechia